Biofidelity

About:

Biofidelity developed a revolutionary molecular diagnostics.

Top Investors: Agilent Technologies, Octopus Ventures, SBI Investment, BlueYard Capital, Longwall Venture

Description:

Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend patients’ lives by enabling early detection of disease and better targeting of treatments with applications spanning oncology, prenatal testing, infectious disease, and organ transplant monitoring. Biofidelity was founded in 2019 and is headquartered of Cambridge, England.

Total Funding Amount:

$60.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2019-02-15

Contact Email:

info(AT)biofidelity.com

Founders:

Barnaby Balmforth, Cameron Frayling

Number of Employees:

11-50

Last Funding Date:

2024-04-03

IPO Status:

Private

Industries: